Inotersen Subcutaneous and Meningococcal vaccine and haemophilus b vaccine Intramuscular

• Generic Name: inotersen
• Dosage Forms: n.a.
• Other Brand Names: Tegsedi

Inotersen injection is used to treat polyneuropathy (nerve disease) of hereditary transthyretin-mediated amyloidosis.

Inotersen is available only under a restricted distribution program called Tegsedi™ REMS (Risk Evaluation and Mitigation Strategy) Program.

• Generic Name: haemophilus b conjugate (prp-t) vaccine / meningococcal conjugate vaccine
• Dosage Forms: n.a.
• Other Brand Names: MenHibrix

Meningococcal polysaccharide vaccine and Haemophilus B conjugate vaccine is an active immunizing combination agent that is used to prevent infection caused by certain groups of meningococcal bacteria and Haemophilus influenza type b (Hib) bacteria. The vaccine works by causing your body to produce its own protection (antibodies) against the disease.

The following information applies only to the meningococcal vaccine used for meningococcal bacteria Groups C and Y

Menhibrix vaccine is recommended for use in children 6 weeks to 18 months of age.

This vaccine is to be administered only by or under the direct supervision of your doctor.